Literature DB >> 3983389

Acute otomastoiditis and its complications: role of CT.

M F Mafee, E L Singleton, G E Valvassori, G A Espinosa, A Kumar, K Aimi.   

Abstract

Acute bacterial (suppurative) otomastoiditis responds to antibiotic treatment; radiologic study is required only when there is clinical suggestion of coalescent mastoiditis, intracranial complications, or an underlying chronic disease. Computed tomography (CT) is the method of choice for evaluating otogenic intra- or extra-cranial complications. CT scans can show stages of disease progression when infection has spread by way of soft tissue, blood, and bone pathways into the dural venous sinuses, meninges, labyrinth, facial nerves, epidural and other intracranial spaces. When there is clinical suggestion of acute coalescent mastoiditis, a CT scan of the temporal bone can confirm the presence of rarefying osteitis, coalescence of the air cells, and subperiosteal abscess.

Entities:  

Mesh:

Year:  1985        PMID: 3983389     DOI: 10.1148/radiology.155.2.3983389

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Petrous apex mucocele: high resolution CT.

Authors:  A Memis; A Memis; H Alper; C Calli; H Ozer; N Ozdamar
Journal:  Neuroradiology       Date:  1994-11       Impact factor: 2.804

2.  Correlation of Pre-operative Temporal Bone CT Scan Findings with Intraoperative Findings in Chronic Otitis Media: Squamous Type.

Authors:  Rajat Agarwal; Rabindra Pradhananga; Heempali Das Dutta; Sharma Poudel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-02-01

Review 3.  Escherichia coli positive infratentorial subdural empyema secondary to mastoiditis and underlying cholesteatoma.

Authors:  Omar Mirza; Vinay Varadarajan; Amir Saam Youshani; David J Willatt
Journal:  BMJ Case Rep       Date:  2014-04-28

4.  Performance of deep learning to detect mastoiditis using multiple conventional radiographs of mastoid.

Authors:  Kyong Joon Lee; Inseon Ryoo; Dongjun Choi; Leonard Sunwoo; Sung-Hye You; Hye Na Jung
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.